Fisher & Paykel Healthcare Corporation Limited
FSPKF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $1,280,300 | $1,758,100 | $1,588,600 | $1,642,400 |
| % Growth | -27.2% | 10.7% | -3.3% | – |
| Cost of Goods Sold | $750,100 | $698,400 | $642,700 | $629,000 |
| Gross Profit | $530,200 | $1,059,700 | $945,900 | $1,013,400 |
| % Margin | 41.4% | 60.3% | 59.5% | 61.7% |
| R&D Expenses | $226,900 | $198,200 | $174,300 | $154,000 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $534,400 | $492,800 | $431,900 | $393,100 |
| Sales & Mktg Exp. | $534,400 | $492,800 | $431,900 | $393,100 |
| Other Operating Expenses | $139,900 | $114,300 | -$7,600 | $40,200 |
| Operating Expenses | $901,200 | $805,300 | $705,200 | $643,100 |
| Operating Income | -$371,000 | $254,400 | $334,700 | $509,100 |
| % Margin | -29% | 14.5% | 21.1% | 31% |
| Other Income/Exp. Net | $874,300 | -$18,700 | $87,300 | $133,900 |
| Pre-Tax Income | $503,300 | $235,700 | $328,000 | $504,200 |
| Tax Expense | $126,100 | $103,100 | $77,700 | $127,300 |
| Net Income | $377,200 | $132,600 | $250,300 | $376,900 |
| % Margin | 29.5% | 7.5% | 15.8% | 22.9% |
| EPS | 0.64 | 0.23 | 0.43 | 0.65 |
| % Growth | 178.3% | -46.5% | -33.8% | – |
| EPS Diluted | 0.64 | 0.23 | 0.43 | 0.65 |
| Weighted Avg Shares Out | 585,543 | 586,728 | 578,140 | 576,949 |
| Weighted Avg Shares Out Dil | 590,297 | 586,179 | 581,631 | 579,993 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,300 | $3,300 | $2,600 | $2,600 |
| Interest Expense | $11,100 | $18,200 | $6,700 | $4,900 |
| Depreciation & Amortization | $139,900 | $114,300 | $99,000 | $96,000 |
| EBITDA | $654,300 | $368,200 | $433,700 | $605,100 |
| % Margin | 51.1% | 20.9% | 27.3% | 36.8% |